Apr 6, 2020
Thank you to all that joined us on Thursday, April 2nd for our live panel discussion where we took a deep dive into the strategic implications of COVID-19 on biopharma companies and investors. It was a great turnout and thank you for your questions. We weren’t...
Mar 31, 2020
Please join us Thursday, April 2nd from 1-2 PM EST to listen to the LIVE panel, COVID 19: Strategic Implications on Biopharma. Following our COVID-19 thought leadership piece on the strategic implications for biopharma, our panelists look forward to taking a deeper...
Mar 20, 2020
These are challenging times for governments, public health administrations and the financial markets. While each biopharma company’s primary concern is the health and safety of its team members, the industry also a responsibility to the world to take an active...
Jan 11, 2020
Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our 2019 Annual Report: Global Trends in Biopharma Transactions applies the latest data to analyze current activities in the life sciences deal...
Jan 11, 2020
Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Medtech 2019 Annual Report: Global Trends in Medtech Transactions applies the latest data to analyze current activities in the medtech deal...
Oct 11, 2019
Every quarter, Locust Walk’s medtech team compiles the latest statistics and trends on strategic medtech transactions and financings, with a focus on upcoming trends.
